Virax Biolabs Group Limited – NASDAQ:VRAX

Virax Biolabs Group Limited stock price today

$0.76
-1.34
-63.81%
Financial Health
0
1
2
3
4
5
6
7
8
9

Virax Biolabs Group Limited stock price monthly change

+85.84%
month

Virax Biolabs Group Limited stock price quarterly change

+85.84%
quarter

Virax Biolabs Group Limited stock price yearly change

+32.08%
year

Virax Biolabs Group Limited key metrics

Market Cap
7.94M
Enterprise value
N/A
P/E
-2.78
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
-23.28
PEG ratio
0.01
EPS
-4.10
Revenue
N/A
EBITDA
-6.18M
Income
-5.88M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Virax Biolabs Group Limited stock price history

Virax Biolabs Group Limited stock forecast

Virax Biolabs Group Limited financial statements

Virax Biolabs Group Limited (NASDAQ:VRAX): Profit margin
Sep 2021 0 -552.41K
Dec 2021 30.95K -162.67K -525.53%
Mar 2022 -92.86K -1.15M 1245.26%
Mar 2023 2.80K -4.01M -143301.79%
Virax Biolabs Group Limited (NASDAQ:VRAX): Analyst Estimates
2026 13.49M 425.19K 3.15%
2027 13.49M 0
  • Analysts Price target

  • Financials & Ratios estimates

Virax Biolabs Group Limited (NASDAQ:VRAX): Debt to assets
Jun 2022 12176 311.35K 2557.1%
Sep 2022 5298687 1.14M 21.56%
Dec 2022 12176 311.35K 2557.1%
Mar 2023 9812416 908.40K 9.26%
Virax Biolabs Group Limited (NASDAQ:VRAX): Cash Flow
Mar 2021 -170.72K 0 123.23K
Sep 2021 -278.68K 0 272.73K
Mar 2022 -530.38K -24.66K 540.46K
Mar 2023 -1.88M -178.40K 6.84M

Virax Biolabs Group Limited alternative data

Virax Biolabs Group Limited (NASDAQ:VRAX): Employee count
Aug 2023 11
Sep 2023 11
Oct 2023 11
Nov 2023 11
Dec 2023 11
Jan 2024 11
Feb 2024 11
Apr 2024 11
May 2024 11
Jun 2024 11
Jul 2024 11

Virax Biolabs Group Limited other data

0.73% -6.52%
of VRAX is owned by hedge funds
18.69K -166.20K
shares is hold by hedge funds
Tuesday, 17 December 2024
prnewswire.com
Tuesday, 10 December 2024
prnewswire.com
Wednesday, 23 October 2024
prnewswire.com
Monday, 16 September 2024
prnewswire.com
accesswire.com
Monday, 9 September 2024
prnewswire.com
Thursday, 29 August 2024
prnewswire.com
Wednesday, 28 August 2024
invezz.com
prnewswire.com
Friday, 23 August 2024
prnewswire.com
Wednesday, 21 August 2024
prnewswire.com
accesswire.com
Monday, 19 August 2024
zacks.com
Friday, 7 June 2024
investorplace.com
Thursday, 6 June 2024
investorplace.com
Thursday, 25 April 2024
prnewswire.com
Tuesday, 16 April 2024
prnewswire.com
Friday, 15 March 2024
prnewswire.com
Wednesday, 27 December 2023
PennyStocks
Wednesday, 14 June 2023
PennyStocks
Wednesday, 19 April 2023
InvestorPlace
Wednesday, 8 March 2023
PennyStocks
Tuesday, 7 March 2023
InvestorPlace
Thursday, 9 February 2023
PennyStocks
Tuesday, 7 February 2023
PennyStocks
Monday, 6 February 2023
PRNewsWire
Wednesday, 4 January 2023
PennyStocks
Friday, 4 November 2022
PennyStocks
Thursday, 3 November 2022
InvestorPlace
Wednesday, 21 September 2022
PennyStocks
  • What's the price of Virax Biolabs Group Limited stock today?

    One share of Virax Biolabs Group Limited stock can currently be purchased for approximately $0.76.

  • When is Virax Biolabs Group Limited's next earnings date?

    Unfortunately, Virax Biolabs Group Limited's (VRAX) next earnings date is currently unknown.

  • Does Virax Biolabs Group Limited pay dividends?

    No, Virax Biolabs Group Limited does not pay dividends.

  • How much money does Virax Biolabs Group Limited make?

    Virax Biolabs Group Limited has a market capitalization of 7.94M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1727.11% to 156.42K US dollars.

  • What is Virax Biolabs Group Limited's stock symbol?

    Virax Biolabs Group Limited is traded on the NASDAQ under the ticker symbol "VRAX".

  • What is Virax Biolabs Group Limited's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Virax Biolabs Group Limited?

    Shares of Virax Biolabs Group Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Virax Biolabs Group Limited have?

    As Jul 2024, Virax Biolabs Group Limited employs 11 workers.

  • When Virax Biolabs Group Limited went public?

    Virax Biolabs Group Limited is publicly traded company for more then 3 years since IPO on 21 Jul 2022.

  • What is Virax Biolabs Group Limited's official website?

    The official website for Virax Biolabs Group Limited is viraxbiolabs.com.

  • How can i contact Virax Biolabs Group Limited?

    Virax Biolabs Group Limited can be reached via phone at +44 20 7788 7414.

Virax Biolabs Group Limited company profile:

Virax Biolabs Group Limited

viraxbiolabs.com
Exchange:

NASDAQ

Full time employees:

17

Industry:

Biotechnology

Sector:

Healthcare

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

30 Broadwick Street
London, W1F 8LX

CIK: 0001885827
ISIN: KYG9495L1251
CUSIP: G9495L109